nodes	percent_of_prediction	percent_of_DWPC	metapath
Lucanthone—APEX1—melanoma	0.82	1	CbGaD
Lucanthone—APEX1—skin epidermis—melanoma	0.00936	0.196	CbGeAlD
Lucanthone—APEX1—hair follicle—melanoma	0.00668	0.14	CbGeAlD
Lucanthone—TOP1—hair follicle—melanoma	0.00467	0.0981	CbGeAlD
Lucanthone—APEX1—neck—melanoma	0.00448	0.094	CbGeAlD
Lucanthone—APEX1—eye—melanoma	0.00333	0.0699	CbGeAlD
Lucanthone—APEX1—retina—melanoma	0.0033	0.0693	CbGeAlD
Lucanthone—APEX1—skin of body—melanoma	0.0029	0.0608	CbGeAlD
Lucanthone—APEX1—mammalian vulva—melanoma	0.00264	0.0555	CbGeAlD
Lucanthone—TOP1—retina—melanoma	0.00231	0.0485	CbGeAlD
Lucanthone—TOP2A—Paclitaxel—Docetaxel—melanoma	0.00208	1	CbGdCrCtD
Lucanthone—APEX1—head—melanoma	0.00189	0.0397	CbGeAlD
Lucanthone—TOP1—mammalian vulva—melanoma	0.00185	0.0388	CbGeAlD
Lucanthone—Procainamide—SCN11A—melanoma	0.00152	0.437	CrCbGaD
Lucanthone—APEX1—lymph node—melanoma	0.00132	0.0278	CbGeAlD
Lucanthone—TOP2A—mammalian vulva—melanoma	0.00132	0.0276	CbGeAlD
Lucanthone—Cinchocaine—SCN10A—melanoma	0.0011	0.318	CrCbGaD
Lucanthone—TOP1—lymph node—melanoma	0.000927	0.0195	CbGeAlD
Lucanthone—TOP2A—lymph node—melanoma	0.00066	0.0138	CbGeAlD
Lucanthone—Procainamide—SCN10A—melanoma	0.000571	0.165	CrCbGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—CDK2—melanoma	0.000241	0.00189	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—CDK2—melanoma	0.000239	0.00188	CbGpPWpGaD
Lucanthone—APEX1—DNA Repair—ATM—melanoma	0.000235	0.00185	CbGpPWpGaD
Lucanthone—APEX1—Synthesis of DNA—RB1—melanoma	0.000232	0.00182	CbGpPWpGaD
Lucanthone—APEX1—S Phase—CDK2—melanoma	0.000231	0.00182	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—TLR4—melanoma	0.000231	0.00182	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—ATM—melanoma	0.000228	0.0018	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—CDK4—melanoma	0.000227	0.00179	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—CDK4—melanoma	0.000226	0.00178	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—ICAM1—melanoma	0.000221	0.00174	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—NOS2—melanoma	0.000219	0.00173	CbGpPWpGaD
Lucanthone—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—ATM—melanoma	0.000219	0.00172	CbGpPWpGaD
Lucanthone—APEX1—S Phase—CDK4—melanoma	0.000218	0.00172	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—CDK4—melanoma	0.000218	0.00172	CbGpPWpGaD
Lucanthone—APEX1—DNA Replication—RB1—melanoma	0.000217	0.00171	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—POT1—melanoma	0.000216	0.0017	CbGpPWpGaD
Lucanthone—TOP1—Caspase Cascade in Apoptosis—AKT1—melanoma	0.000215	0.00169	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—NODAL—melanoma	0.000214	0.00169	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—APC—melanoma	0.000214	0.00168	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—NOS2—melanoma	0.000212	0.00167	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—EGF—melanoma	0.000212	0.00167	CbGpPWpGaD
Lucanthone—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—NOTCH1—melanoma	0.00021	0.00165	CbGpPWpGaD
Lucanthone—APEX1—TSH signaling pathway—STAT3—melanoma	0.0002	0.00158	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—CASP8—melanoma	0.000199	0.00157	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—PPARG—melanoma	0.000198	0.00156	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—RB1—melanoma	0.000196	0.00155	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—IGF1—melanoma	0.000196	0.00154	CbGpPWpGaD
Lucanthone—TOP2A—Gastric Cancer Network 2—CTNNB1—melanoma	0.000195	0.00153	CbGpPWpGaD
Lucanthone—APEX1—TSH signaling pathway—MAPK3—melanoma	0.000191	0.00151	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—MAP3K5—melanoma	0.000191	0.0015	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—CASP10—melanoma	0.000191	0.0015	CbGpPWpGaD
Lucanthone—APEX1—S Phase—RB1—melanoma	0.00019	0.00149	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—MAP2K1—melanoma	0.000189	0.00149	CbGpPWpGaD
Lucanthone—Amiodarone—ABCB1—melanoma	0.000189	0.0545	CrCbGaD
Lucanthone—APEX1—TSH signaling pathway—MYC—melanoma	0.000186	0.00147	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—SKP2—melanoma	0.000182	0.00144	CbGpPWpGaD
Lucanthone—APEX1—TSH signaling pathway—MAPK1—melanoma	0.000182	0.00143	CbGpPWpGaD
Lucanthone—APEX1—Synthesis of DNA—CDKN1B—melanoma	0.00018	0.00142	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—FGF2—melanoma	0.00018	0.00142	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—DCC—melanoma	0.000177	0.00139	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—APAF1—melanoma	0.000171	0.00135	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—BCL2—melanoma	0.000171	0.00135	CbGpPWpGaD
Lucanthone—APEX1—DNA Replication—CDKN1B—melanoma	0.000169	0.00133	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—MDM2—melanoma	0.000169	0.00133	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—IFNG—melanoma	0.000168	0.00132	CbGpPWpGaD
Lucanthone—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—CDKN2A—melanoma	0.000167	0.00131	CbGpPWpGaD
Lucanthone—APEX1—Synthesis of DNA—CDKN1A—melanoma	0.000166	0.00131	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—ERBB2—melanoma	0.000166	0.00131	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—E2F1—melanoma	0.000163	0.00129	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—PTGS2—melanoma	0.000162	0.00128	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—WT1—melanoma	0.000162	0.00128	CbGpPWpGaD
Lucanthone—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—MDM2—melanoma	0.000162	0.00127	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—REC8—melanoma	0.000162	0.00127	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—PTGS2—melanoma	0.000161	0.00127	CbGpPWpGaD
Lucanthone—APEX1—TSH signaling pathway—PIK3CA—melanoma	0.000158	0.00124	CbGpPWpGaD
Lucanthone—TOP2A—Gastric Cancer Network 2—MYC—melanoma	0.000158	0.00124	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—CXCL8—melanoma	0.000156	0.00123	CbGpPWpGaD
Lucanthone—APEX1—DNA Replication—CDKN1A—melanoma	0.000156	0.00123	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—PCNA—melanoma	0.000154	0.00121	CbGpPWpGaD
Lucanthone—TOP2A—Gastric Cancer Network 2—EGFR—melanoma	0.000154	0.00121	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—CDKN1B—melanoma	0.000154	0.00121	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—CDKN1B—melanoma	0.000153	0.0012	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—CASP3—melanoma	0.000151	0.00119	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—CASP3—melanoma	0.00015	0.00118	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—IL2—melanoma	0.00015	0.00118	CbGpPWpGaD
Lucanthone—APEX1—S Phase—CDKN1B—melanoma	0.000148	0.00116	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—CCND1—melanoma	0.000147	0.00116	CbGpPWpGaD
Lucanthone—APEX1—TSH signaling pathway—HRAS—melanoma	0.000146	0.00115	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—CCND1—melanoma	0.000146	0.00115	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—CTNNB1—melanoma	0.000145	0.00114	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—SKP2—melanoma	0.000145	0.00114	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—CDKN1A—melanoma	0.000142	0.00112	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—PTEN—melanoma	0.000142	0.00112	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—MMP9—melanoma	0.000142	0.00111	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—NFKB1—melanoma	0.000141	0.00111	CbGpPWpGaD
Lucanthone—APEX1—S Phase—CCND1—melanoma	0.000141	0.00111	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—CDK2—melanoma	0.000141	0.00111	CbGpPWpGaD
Lucanthone—APEX1—S Phase—CDKN1A—melanoma	0.000136	0.00107	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—PTEN—melanoma	0.000136	0.00107	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—CDK4—melanoma	0.000133	0.00105	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—PKMYT1—melanoma	0.000133	0.00104	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—INCENP—melanoma	0.000133	0.00104	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—AURKA—melanoma	0.000132	0.00104	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—MLH1—melanoma	0.000131	0.00103	CbGpPWpGaD
Lucanthone—TOP2A—Gastric Cancer Network 2—TP53—melanoma	0.000129	0.00102	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—SKP2—melanoma	0.000129	0.00102	CbGpPWpGaD
Lucanthone—APEX1—TSH signaling pathway—AKT1—melanoma	0.000129	0.00102	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	0.000128	0.00101	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—CDKN2B—melanoma	0.000125	0.000986	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—GNA11—melanoma	0.000121	0.000955	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	0.000121	0.000953	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—MAPK3—melanoma	0.00012	0.000946	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—PKMYT1—melanoma	0.000119	0.000934	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—INCENP—melanoma	0.000119	0.000934	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—AURKA—melanoma	0.000118	0.000931	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—MYC—melanoma	0.000118	0.000927	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—MYC—melanoma	0.000117	0.000921	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—RB1—melanoma	0.000116	0.000912	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	0.000115	0.000907	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	0.000115	0.000907	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—E2F1—melanoma	0.000115	0.000905	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—MAPK1—melanoma	0.000114	0.000901	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—EGFR—melanoma	0.000114	0.0009	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—HDAC2—melanoma	0.000114	0.000898	CbGpPWpGaD
Lucanthone—APEX1—S Phase—MYC—melanoma	0.000113	0.000891	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—GNAQ—melanoma	0.000113	0.000888	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—TNF—melanoma	0.00011	0.000864	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—TNF—melanoma	0.000109	0.000858	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	0.000109	0.000857	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—PCNA—melanoma	0.000108	0.000854	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—NGFR—melanoma	0.000104	0.000819	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	0.0001	0.000787	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—POT1—melanoma	9.98e-05	0.000786	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—CDKN2B—melanoma	9.94e-05	0.000782	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—CDK2—melanoma	9.92e-05	0.000781	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—MDM2—melanoma	9.88e-05	0.000778	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—TP53—melanoma	9.67e-05	0.000761	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—TP53—melanoma	9.6e-05	0.000756	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN2B—melanoma	9.49e-05	0.000747	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—CDK4—melanoma	9.37e-05	0.000738	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—TP53—melanoma	9.28e-05	0.000731	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—ABCB1—melanoma	9.27e-05	0.00073	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—E2F1—melanoma	9.12e-05	0.000718	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—CDKN1B—melanoma	9.02e-05	0.00071	CbGpPWpGaD
Lucanthone—Flurazepam—ABCB1—melanoma	8.95e-05	0.0258	CrCbGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—PRKCA—melanoma	8.93e-05	0.000703	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—FGF1—melanoma	8.9e-05	0.000701	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—CDKN2B—melanoma	8.88e-05	0.000699	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—IL6—melanoma	8.79e-05	0.000692	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—E2F1—melanoma	8.71e-05	0.000686	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—PDGFRA—melanoma	8.62e-05	0.000679	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—CCND1—melanoma	8.6e-05	0.000677	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—PCNA—melanoma	8.6e-05	0.000677	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—PRKCA—melanoma	8.54e-05	0.000672	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—IL6—melanoma	8.5e-05	0.000669	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—FASLG—melanoma	8.37e-05	0.000659	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—CDKN1A—melanoma	8.32e-05	0.000655	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—PCNA—melanoma	8.22e-05	0.000647	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	8.17e-05	0.000643	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—E2F1—melanoma	8.15e-05	0.000642	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—RB1—melanoma	8.15e-05	0.000642	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—FAS—melanoma	8.07e-05	0.000635	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—PRKCA—melanoma	7.99e-05	0.000629	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—RAC1—melanoma	7.91e-05	0.000623	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—CDK2—melanoma	7.87e-05	0.000619	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—FAS—melanoma	7.75e-05	0.00061	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—PCNA—melanoma	7.69e-05	0.000605	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—CDK2—melanoma	7.51e-05	0.000592	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—CDK4—melanoma	7.43e-05	0.000585	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—TERT—melanoma	7.43e-05	0.000585	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—CDKN2A—melanoma	7.17e-05	0.000564	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—ATM—melanoma	7.13e-05	0.000562	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—CDK4—melanoma	7.1e-05	0.000559	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—CDK2—melanoma	7.03e-05	0.000554	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—MYC—melanoma	6.9e-05	0.000543	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—CDK4—melanoma	6.82e-05	0.000537	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—SKP2—melanoma	6.69e-05	0.000527	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—APC—melanoma	6.69e-05	0.000526	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—ATM—melanoma	6.68e-05	0.000526	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—CDK4—melanoma	6.65e-05	0.000523	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—NOS2—melanoma	6.63e-05	0.000522	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—EGF—melanoma	6.61e-05	0.00052	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—RB1—melanoma	6.46e-05	0.000509	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—CDKN1B—melanoma	6.35e-05	0.0005	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—CASP8—melanoma	6.23e-05	0.00049	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—PPARG—melanoma	6.19e-05	0.000488	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—IGF1—melanoma	6.12e-05	0.000482	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—AURKA—melanoma	6.12e-05	0.000482	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—CCND1—melanoma	6.05e-05	0.000477	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—MLH1—melanoma	6.05e-05	0.000476	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—SKP2—melanoma	5.98e-05	0.000471	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—MAP2K1—melanoma	5.92e-05	0.000466	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—CDKN1A—melanoma	5.86e-05	0.000461	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—RB1—melanoma	5.78e-05	0.000455	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—CDKN2A—melanoma	5.68e-05	0.000447	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—TP53—melanoma	5.67e-05	0.000446	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—FGF2—melanoma	5.63e-05	0.000443	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—AURKA—melanoma	5.47e-05	0.000431	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—BCL2—melanoma	5.34e-05	0.000421	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—APEX1—melanoma	5.31e-05	0.000418	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—MDM2—melanoma	5.27e-05	0.000415	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—ERBB2—melanoma	5.19e-05	0.000409	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—CDKN2A—melanoma	5.08e-05	0.0004	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—melanoma	5.08e-05	0.0004	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—CDKN1B—melanoma	5.03e-05	0.000396	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—MDM2—melanoma	4.93e-05	0.000388	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—MYC—melanoma	4.86e-05	0.000382	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1B—melanoma	4.81e-05	0.000378	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—CCND1—melanoma	4.8e-05	0.000378	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—APEX1—melanoma	4.75e-05	0.000374	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—CASP3—melanoma	4.71e-05	0.000371	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—CDKN1A—melanoma	4.64e-05	0.000366	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—CDKN2B—melanoma	4.6e-05	0.000362	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—melanoma	4.59e-05	0.000361	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—CTNNB1—melanoma	4.54e-05	0.000358	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—CDKN1B—melanoma	4.5e-05	0.000354	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1A—melanoma	4.44e-05	0.000349	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—PTEN—melanoma	4.43e-05	0.000349	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—NFKB1—melanoma	4.41e-05	0.000347	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—CCND1—melanoma	4.29e-05	0.000338	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—PTEN—melanoma	4.25e-05	0.000335	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—E2F1—melanoma	4.22e-05	0.000332	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—CDKN1A—melanoma	4.15e-05	0.000327	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—PRKCA—melanoma	4.13e-05	0.000325	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—CDKN2B—melanoma	4.11e-05	0.000323	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	4e-05	0.000315	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—PCNA—melanoma	3.98e-05	0.000313	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—MAPK3—melanoma	3.96e-05	0.000312	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—MYC—melanoma	3.85e-05	0.000303	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	3.78e-05	0.000298	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—E2F1—melanoma	3.77e-05	0.000297	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—MAPK1—melanoma	3.77e-05	0.000297	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—PRKCA—melanoma	3.69e-05	0.000291	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—melanoma	3.68e-05	0.00029	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—CDK2—melanoma	3.64e-05	0.000286	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	3.6e-05	0.000283	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	3.6e-05	0.000283	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—PCNA—melanoma	3.56e-05	0.00028	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—MAPK3—melanoma	3.54e-05	0.000279	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—MYC—melanoma	3.44e-05	0.000271	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—CDK4—melanoma	3.44e-05	0.000271	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—TERT—melanoma	3.43e-05	0.00027	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—melanoma	3.43e-05	0.00027	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	3.4e-05	0.000268	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—MAPK1—melanoma	3.37e-05	0.000265	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—CDK2—melanoma	3.25e-05	0.000256	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	3.12e-05	0.000246	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—ATM—melanoma	3.09e-05	0.000243	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—CDK4—melanoma	3.07e-05	0.000242	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—melanoma	3.02e-05	0.000238	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—RB1—melanoma	2.99e-05	0.000235	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—TP53—melanoma	2.9e-05	0.000228	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—TP53—melanoma	2.83e-05	0.000223	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—RB1—melanoma	2.67e-05	0.00021	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—IL6—melanoma	2.65e-05	0.000209	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—CDKN2A—melanoma	2.63e-05	0.000207	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	2.55e-05	0.000201	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—CDKN2A—melanoma	2.35e-05	0.000185	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—CDKN1B—melanoma	2.33e-05	0.000183	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—MDM2—melanoma	2.28e-05	0.000179	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—CCND1—melanoma	2.22e-05	0.000175	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—CDKN1A—melanoma	2.15e-05	0.000169	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—CDKN1B—melanoma	2.08e-05	0.000164	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—CCND1—melanoma	1.99e-05	0.000156	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—CDKN1A—melanoma	1.92e-05	0.000151	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—MAPK3—melanoma	1.83e-05	0.000144	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—MYC—melanoma	1.78e-05	0.00014	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—MAPK1—melanoma	1.74e-05	0.000137	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—MAPK3—melanoma	1.64e-05	0.000129	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—MYC—melanoma	1.59e-05	0.000125	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—MAPK1—melanoma	1.56e-05	0.000123	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—TP53—melanoma	1.31e-05	0.000103	CbGpPWpGaD
